Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Maravai Lifesciences Holdings (MRVI) Return on Assets (2021 - 2025)

Historic Return on Assets for Maravai Lifesciences Holdings (MRVI) over the last 5 years, with Q3 2025 value amounting to 0.24%.

  • Maravai Lifesciences Holdings' Return on Assets fell 100.0% to 0.24% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.24%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.21% for FY2024, which is 1300.0% down from last year.
  • Maravai Lifesciences Holdings' Return on Assets amounted to 0.24% in Q3 2025, which was down 100.0% from 0.37% recorded in Q2 2025.
  • Maravai Lifesciences Holdings' 5-year Return on Assets high stood at 0.27% for Q1 2022, and its period low was 0.37% during Q2 2025.
  • For the 5-year period, Maravai Lifesciences Holdings' Return on Assets averaged around 0.02%, with its median value being 0.08% (2023).
  • Its Return on Assets has fluctuated over the past 5 years, first skyrocketed by 1700bps in 2022, then plummeted by -2900bps in 2023.
  • Maravai Lifesciences Holdings' Return on Assets (Quarter) stood at 0.25% in 2021, then fell by -12bps to 0.22% in 2022, then plummeted by -134bps to 0.07% in 2023, then tumbled by -208bps to 0.23% in 2024, then fell by -8bps to 0.24% in 2025.
  • Its Return on Assets was 0.24% in Q3 2025, compared to 0.37% in Q2 2025 and 0.29% in Q1 2025.